172 related articles for article (PubMed ID: 38634984)
21. Triptans for acute cluster headache.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2010 Apr; (4):CD008042. PubMed ID: 20393964
[TBL] [Abstract][Full Text] [Related]
22. Twenty-five years of triptans - a nationwide population study.
Davidsson OB; Olofsson IA; Kogelman LJ; Andersen MA; Rostgaard K; Hjalgrim H; Olesen J; Hansen TF
Cephalalgia; 2021 Jul; 41(8):894-904. PubMed ID: 33583217
[TBL] [Abstract][Full Text] [Related]
23. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].
Perearnau P; Vuillemet F; Schick J; Weill G
Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890
[TBL] [Abstract][Full Text] [Related]
24. Implications for the migraine SNP rs1835740 in a Swedish cluster headache population.
Ran C; Fourier C; Zinnegger M; Steinberg A; Sjöstrand C; Waldenlind E; Belin AC
J Headache Pain; 2018 Nov; 19(1):100. PubMed ID: 30382894
[TBL] [Abstract][Full Text] [Related]
25. Effects of switching acute treatment on disability in migraine patients using triptans.
Serrano D; Buse DC; Kori SH; Papapetropoulos S; Cunanan CM; Manack AN; Reed ML; Lipton RB
Headache; 2013 Oct; 53(9):1415-29. PubMed ID: 23808937
[TBL] [Abstract][Full Text] [Related]
26. Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database - A cohort study.
Zebenholzer K; Gall W; Gleiss A; Pavelic AR; Wöber C
Headache; 2022 May; 62(5):604-612. PubMed ID: 35593784
[TBL] [Abstract][Full Text] [Related]
27. Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data.
Zebenholzer K; Gall W; Wöber C
J Headache Pain; 2018 May; 19(1):34. PubMed ID: 29777424
[TBL] [Abstract][Full Text] [Related]
28. Triptans for acute cluster headache.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD008042. PubMed ID: 24353996
[TBL] [Abstract][Full Text] [Related]
29. Triptan treatment is associated with a higher number of red wine-induced migraine episodes: An exploratory questionnaire-based survey.
Nedergaard L; Martens MC; Christensen MDB; Pellesi L
Pain Pract; 2024 Mar; ():. PubMed ID: 38450841
[TBL] [Abstract][Full Text] [Related]
30. The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.
Deighton AM; Harris LA; Johnston K; Hogan S; Quaranta LA; L'Italien G; Coric V
BMC Neurol; 2021 Nov; 21(1):425. PubMed ID: 34727873
[TBL] [Abstract][Full Text] [Related]
31. Triptans: low utilization and high turnover in the general population.
Panconesi A; Pavone E; Franchini M; Mennuti N; Bartolozzi M; Guidi L; Banfi R
Cephalalgia; 2010 May; 30(5):576-81. PubMed ID: 19732070
[TBL] [Abstract][Full Text] [Related]
32. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
Ng-Mak DS; Chen YT; Ho TW; Stanford B; Roset M
Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
[TBL] [Abstract][Full Text] [Related]
33. Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.
Lugardon S; Roussel H; Sciortino V; Montastruc JL; Lapeyre-Mestre M
Eur J Clin Pharmacol; 2007 Aug; 63(8):801-7. PubMed ID: 17576547
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data.
Choong CK; Ford JH; Nyhuis AW; Joshi SG; Robinson RL; Aurora SK; Martinez JM
Headache; 2017 Oct; 57(9):1359-1374. PubMed ID: 28581025
[TBL] [Abstract][Full Text] [Related]
35. Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks.
Lee JH; Shewale AR; Barthold D; Devine B
Headache; 2021 Nov; 61(10):1499-1510. PubMed ID: 34841520
[TBL] [Abstract][Full Text] [Related]
36. Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
Mathew PG; Pavlovic JM; Lettich A; Wells RE; Robertson CE; Mullin K; Charleston Iv L; Dodick DW; Schwedt TJ
Headache; 2014 Apr; 54(4):698-708. PubMed ID: 24512184
[TBL] [Abstract][Full Text] [Related]
37. Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms.
Katsarou MS; Papasavva M; Latsi R; Toliza I; Gkaros AP; Papakonstantinou S; Gatzonis S; Mitsikostas DD; Kovatsi L; Izotov BN; Tsatsakis AM; Drakoulis N
J Mol Neurosci; 2018 Jul; 65(3):367-376. PubMed ID: 29959630
[TBL] [Abstract][Full Text] [Related]
38. Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population.
Papasavva M; Katsarou MS; Vikelis M; Mitropoulou E; Dermitzakis EV; Papakonstantinou S; Arvaniti C; Mitsikostas DD; Gozes I; Tsatsakis AM; Drakoulis N
J Mol Neurosci; 2020 Mar; 70(3):467-474. PubMed ID: 31768945
[TBL] [Abstract][Full Text] [Related]
39. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
Marcus SC; Shewale AR; Silberstein SD; Lipton RB; Young WB; Viswanathan HN; Doshi JA
Cephalalgia; 2020 Jun; 40(7):639-649. PubMed ID: 32223301
[TBL] [Abstract][Full Text] [Related]
40. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure.
Sacco S; Lampl C; Amin FM; Braschinsky M; Deligianni C; Uludüz D; Versijpt J; Ducros A; Gil-Gouveia R; Katsarava Z; Martelletti P; Ornello R; Raffaelli B; Boucherie DM; Pozo-Rosich P; Sanchez-Del-Rio M; Sinclair A; Maassen van den Brink A; Reuter U
J Headache Pain; 2022 Oct; 23(1):133. PubMed ID: 36224519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
